Clinical trial · Interventional
Evaluating the Effectiveness of Aromatherapy for Alleviating Distress in Breast Cancer Patients Before Radiotherapy.
NCT06766058CI-TRIAL-00111781recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
ASTER is a multi-part study that aims to prospectively establish evidence for the implementation of aromatherapy as complementary therapy within cancer care in the Singapore context. ASTER 2 study evaluates how extracts from Asian aromatic plants with familiar aromas introduced as inhalation therapy can alleviate distress in breast cancer patients scheduled to undergo radiotherapy (RT).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Asian plant extract blend | Other | — | UNRESOLVED |
| Carrier oil | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- PLACEBO_COMPARATOR
- label
- Control Group
- interventionNames
- Other: Carrier oil
- type
- EXPERIMENTAL
- label
- Intervention Group
- interventionNames
- Other: Asian plant extract blend
Primary outcomes (3)
- measure
- The impact of Inhalation Aromatherapy Intervention on Distress.
- timeFrame
- Baseline (on CT Simulation Day), Before Intervention (on RT day), and After 20 minutes of Aromatherapy Intervention (on RT day).
- description
- Changes of Distress Score (Distress Score from a scale of 0 - 10).
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 21 Years
- Maximum age
- 99 Years
Show eligibility criteria text
Inclusion Criteria: 1. Aged 21 years old and above 2. Confirmed diagnosis of breast cancer of any stage 3. Scheduled to undergo radiotherapy for the first time 4. Capable of providing informed consent Exclusion Criteria: 1. Physically or mentally incapable of providing verbal/written consent 2. Known or suspected hypersensitivity/allergy to essential oils or any components of the formulations 3. Airway hypersensitivity to fragrances, paint fumes or turpentine 4. Taking medications for anxiety (e.g. benzodiazepines) before radiotherapy 5. Pregnant, breastfeeding, or intending to conceive during study period
References
Publications (0)
Data not yet available
No reference posted for this study.